| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/12/2009 | WO2009030734A1 Intraoperative trifunctional antibody administration for prophylaxis of intraperitoneal tumor cell dissemination |
| 03/12/2009 | WO2009030684A2 Reduction of concomitant infections in pigs by the use of pcv2 antigen |
| 03/12/2009 | WO2009030676A2 Pharmaceutical composition comprising a japanese encephalitis virus for vaccination of patients of at least 40 years of age |
| 03/12/2009 | WO2009030368A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 03/12/2009 | WO2009030285A1 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 03/12/2009 | WO2009030239A1 Novel methods and antibodies for treating cancer |
| 03/12/2009 | WO2009030103A1 The uses of salmonella typhi or salmonella paratyphi for preparation of medicaments for combating tumors |
| 03/12/2009 | WO2009030084A1 NEW FUNCTIONS AND USES OF HUMAN ONCOGENE-LIKE SMALL G PROTEIN RabJ |
| 03/12/2009 | WO2009030025A1 Porcine adeno-associated viruses |
| 03/12/2009 | WO2009015247A3 Chimeric hiv antigens |
| 03/12/2009 | WO2009014650A3 Recombinant vibrio cholerae exotoxins |
| 03/12/2009 | WO2009009670A3 Apparatus and method for harvesting biologics from eggs |
| 03/12/2009 | WO2008141226A3 Recombinant bacteria comprising vectors for expression of nucleic acid sequences encoding antigens |
| 03/12/2009 | WO2008135446A3 Klebsiella antigens |
| 03/12/2009 | WO2008133645A3 Combination vaccine for prevention of tularemia |
| 03/12/2009 | WO2008129559A3 Antigenic polysaccharides and process for their preparation |
| 03/12/2009 | WO2008122441A4 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 03/12/2009 | WO2008121461A3 Vaccine for activating helper function of cd8+ tcells |
| 03/12/2009 | WO2008115631A3 Plant-produced compositions for treating papillomavirus infection and related methods |
| 03/12/2009 | WO2008079849A3 Antibodies to insulin-like growth factor receptor |
| 03/12/2009 | WO2008064031A3 Potent activation of antigen presenting cells by the hepatitis a virus cellular receptor 1 and its role in the regulation of immune responses |
| 03/12/2009 | WO2008040362A3 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 03/12/2009 | WO2008022196A3 Development of dengue virus vaccine components |
| 03/12/2009 | WO2006020266A3 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 03/12/2009 | US20090070890 Product |
| 03/12/2009 | US20090069623 Methods and compositions for treatment or prevention of radiation-induced fibrosis |
| 03/12/2009 | US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
| 03/12/2009 | US20090069264 Toxoplasma gondii nucleic acid molecules |
| 03/12/2009 | US20090069236 PROCESS FOR THE PREPARATION OF HYPOALLERGENIC MAJOR BIRCH POLLEN ALLERGEN rBet v 1 |
| 03/12/2009 | US20090068641 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 03/12/2009 | US20090068636 Viral protein |
| 03/12/2009 | US20090068274 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/12/2009 | US20090068254 Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant |
| 03/12/2009 | US20090068251 Methods and compositions for promoting wound healing |
| 03/12/2009 | US20090068235 Immunogenic cd19 peptides |
| 03/12/2009 | US20090068234 Methods and compositions for the treatment and prevention of cancer |
| 03/12/2009 | US20090068233 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 03/12/2009 | US20090068232 Attenuated mycoplasma gallisepticum strains |
| 03/12/2009 | US20090068231 Live attenuated mycoplasma strains |
| 03/12/2009 | US20090068230 Enterohemorrhagic escherichia coli vaccine |
| 03/12/2009 | US20090068229 Modified surface antigen |
| 03/12/2009 | US20090068228 Vaccine; effective combination of pertussis filamentous hemagglutinin (FHA), pertactin (PRN, 69K-OMP), pertussis fimbriae (FIM) and pertussis toxin (PT); industrial scale purification |
| 03/12/2009 | US20090068227 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 03/12/2009 | US20090068226 Bacterial superantigen vaccines |
| 03/12/2009 | US20090068225 Compositions and methods for orthopox virus vaccination |
| 03/12/2009 | US20090068224 Method to identify polypeptide toll-like receptor (tlr) ligands |
| 03/12/2009 | US20090068223 Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| 03/12/2009 | US20090068222 Bacterial expression vectors that successfully eliminate or attenuate the type I IFN response that is usually mounted by mammalian host cells in response to invasion by a bacterial expression vector |
| 03/12/2009 | US20090068221 Virus-like particles as vaccines for paramyxovirus |
| 03/12/2009 | US20090068220 Compositions and methods for diagnosing and treating urinary tract infections |
| 03/12/2009 | US20090068218 Antigens for Vaccination Against and Detection of Mycoplasma Suis |
| 03/12/2009 | US20090068217 Recombinant vaccine for preventing and treating porcine atrophic rhinitis |
| 03/12/2009 | US20090068216 Modified surface antigen |
| 03/12/2009 | US20090068215 Herpes simplex virus mutant icp0 protein |
| 03/12/2009 | US20090068214 Methods and Compositions for Producing an Enhanced Immune Response to a Human Papillomavirus Immunogen |
| 03/12/2009 | US20090068213 Immunogenic composition for early detection of dengue virus |
| 03/12/2009 | US20090068212 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans |
| 03/12/2009 | US20090068211 Immunogenically-enhanced polypeptides and related methods |
| 03/12/2009 | US20090068210 Immunotherapy for hematological malignancies |
| 03/12/2009 | US20090068209 Cytotoxic Lymphocyte |
| 03/12/2009 | US20090068208 Long term disease modification using immunostimulatory oligonucleotides |
| 03/12/2009 | US20090068207 Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease |
| 03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 03/12/2009 | US20090068204 Morinda citrifolia Based Formulations for Regulating T cell Immunomodulation in Neonatal Stock Animals |
| 03/12/2009 | US20090068203 Methods for treating cardiovascular disease using a soluble CTLA4 Molecule |
| 03/12/2009 | US20090068202 Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 03/12/2009 | US20090068201 Methods of treatment using antibodies to neutrokine-alpha |
| 03/12/2009 | US20090068200 Method for Prongf Assay for in Vitro Diagnosis of Cancer in Particular Breast, Thyroid or Lung Cancer, and Therapeutic Use of Prongf |
| 03/12/2009 | US20090068199 Methods for Treating and Detecting Beta-Cell Disease |
| 03/12/2009 | US20090068198 Antibody and Uses Thereof |
| 03/12/2009 | US20090068197 Mycobacterial disease detection, treatment, and drug discovery |
| 03/12/2009 | US20090068196 Pharmaceutical formulation of an antibody against IL13Ralpha1 |
| 03/12/2009 | US20090068195 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 03/12/2009 | US20090068194 Antibodies and Their Use In The Treatment, Prevention and Diagnosis of a Disease Associated With SOD1 Abnormalities |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068192 The antibodies are immunomodulators of diseases such as cancer, autoimmune, inflammatory and infectious diseases |
| 03/12/2009 | US20090068191 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of the Pseudomonas Aeruginosa IATS 011 Serotype |
| 03/12/2009 | US20090068190 Anti-proliferative combinations |
| 03/12/2009 | US20090068189 Monoclonal Antibody to Human TGF-Beta Induced Gene-H3 and Use Thereof |
| 03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
| 03/12/2009 | US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor |
| 03/12/2009 | US20090068186 MAP3Ks as modifiers of the p53 pathway and methods of use |
| 03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/12/2009 | US20090068184 Major histocompatibility complex polypeptide hybrid for use in prevention and/or treatment of infection, inflammatory, autoimmune and/or malignancy |
| 03/12/2009 | US20090068183 Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 03/12/2009 | US20090068182 Cytotoxicity mediation of cells evidencing surface expression of CD9 |
| 03/12/2009 | US20090068181 Bispecific antibodies |
| 03/12/2009 | US20090068180 treating rheumatoid arthritis or graft-versus-host disease, comprising administering a Sphingosine-1-phosphate lyase inhibitors such as 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime and at least one additional immunosuppressant and/or antiinflammatory agent |
| 03/12/2009 | US20090068179 Methods for Inhibiting Carcinogenesis and/or Metastasis in an Individual with Endogenous C-Met Ligands and Inhibitors |
| 03/12/2009 | US20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin |
| 03/12/2009 | US20090068177 Optimized Fc variants and methods for their generation |
| 03/12/2009 | US20090068176 Human neutralizing antibodies aganst hemolytic uremic syndrome |
| 03/12/2009 | US20090068175 Optimized FC Variants and Methods for Their Generation |
| 03/12/2009 | US20090068174 Therapeutic alkaline protease compositions and use in facilitating the transport of agents across the gastrointestinal mucosal lining |
| 03/12/2009 | US20090068173 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11 |
| 03/12/2009 | US20090068172 Compositions and methods comprising binding proteins for adalimumab |
| 03/12/2009 | US20090068171 Protein markers for the detection of thyroid cancer metastasis |
| 03/12/2009 | US20090068170 Droplet-based selection |
| 03/12/2009 | US20090068169 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use |